Bausch Health Companies (BHC) Liabilities from Discontinued Operations (2010 - 2017)

Bausch Health Companies (BHC) reported Liabilities from Discontinued Operations of 49000000.0 for Q1 2017, down 14.04% sequentially from 57000000.0 in Q4 2016.

Bausch Health Companies (BHC) Liabilities from Discontinued Operations (2010 - 2017) Analysis & Trends

Bausch Health Companies (BHC) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 49000000.0 in Q1 2017.

  • For the quarter ending Q1 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 49000000.0; the trailing twelve-month figure through Mar 2017 stood at 49000000.0 (changed N/A YoY), and the FY2016 full-year result was 57000000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations fell to 49000000.0 in Q1 2017, from 57000000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 57000000.0 in Q4 2016 to a low of 27100000.0 in Q2 2014.
  • A 3-year average of 44366666.67 and a median of 49000000.0 in 2017 frame the typical range for Liabilities from Discontinued Operations.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2017 49.00 Mn
Mar 31, 2017 49.00 Mn
Dec 31, 2016 57.00 Mn
Dec 31, 2016 57.00 Mn
Jun 30, 2014 27.10 Mn
Jun 30, 2014 27.10 Mn
Jun 30, 2010 1.08 Mn
Jun 30, 2010 1.08 Mn